Chronic graft-versus-host disease (GVHD) is a syndrome of disordered immunity in which a variety of oppor-tunistic respiratory infections have been documented. Restrictive pulmonary disease without advanced fibrotic changes has been also known to occur; obstructive lower airways disease related to chronic GVHD has apparently not been referred to. ' 2We report a patient with chronic GVHD and irreversible airways obstruction who died in respiratory failure caused by generalised bronchiolar damage progressing over a few months. Lung function studies showed severe airflow limitation and a leftward shift in the pressure-volume curve indicating a loss of elastic recoil pressure. Postmortem pulmonary lesions were consistent with a necrotising...
SummaryObliterative bronchiolitis (OB) is known to result from many causes, such as post-bone marrow...
Late-onset noninfectious pulmonary complications (LONIPCs) are life-threatening complications of bon...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...
Several noninfectious pulmonary complications can be associated with chronic graft versus host disea...
Bronchiolitis obliterans (BO) is a nonspecific inflammatory injury affecting primarily the small air...
GVHD is the principal complication of allogeneic BMT. N Vascular endothelial damage and increased s...
Pulmonary graft vs. host disease is a diverse and underestimated complication following allogenic he...
PURPOSE: Pulmonary chronic graft versus host disease (GVHD) is one of the thoracic manifestations th...
AbstractBronchiolitis obliterans (BrOb), a late complication of bone marrow transplantation (BMT), i...
Bronchiolitis obliterans syndrome (BOS) is a progressive, insidious, and often fatal lung alloreacti...
International audienceGraft-versus-host disease (GVHD) is a classic and frequent multisystemic compl...
A woman with lymphoblastic lymphoma was treated with combination chemotherapy. She subsequently beca...
Background: Although the biology of steroid-refractory acute GVHD is still unknown, the pathogenesis...
Copyright © 2015 Gursel Gunes et al. This is an open access article distributed under the Creative C...
It is unknown if diminished pulmonary function early after allogeneic hematopoietic transplant is as...
SummaryObliterative bronchiolitis (OB) is known to result from many causes, such as post-bone marrow...
Late-onset noninfectious pulmonary complications (LONIPCs) are life-threatening complications of bon...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...
Several noninfectious pulmonary complications can be associated with chronic graft versus host disea...
Bronchiolitis obliterans (BO) is a nonspecific inflammatory injury affecting primarily the small air...
GVHD is the principal complication of allogeneic BMT. N Vascular endothelial damage and increased s...
Pulmonary graft vs. host disease is a diverse and underestimated complication following allogenic he...
PURPOSE: Pulmonary chronic graft versus host disease (GVHD) is one of the thoracic manifestations th...
AbstractBronchiolitis obliterans (BrOb), a late complication of bone marrow transplantation (BMT), i...
Bronchiolitis obliterans syndrome (BOS) is a progressive, insidious, and often fatal lung alloreacti...
International audienceGraft-versus-host disease (GVHD) is a classic and frequent multisystemic compl...
A woman with lymphoblastic lymphoma was treated with combination chemotherapy. She subsequently beca...
Background: Although the biology of steroid-refractory acute GVHD is still unknown, the pathogenesis...
Copyright © 2015 Gursel Gunes et al. This is an open access article distributed under the Creative C...
It is unknown if diminished pulmonary function early after allogeneic hematopoietic transplant is as...
SummaryObliterative bronchiolitis (OB) is known to result from many causes, such as post-bone marrow...
Late-onset noninfectious pulmonary complications (LONIPCs) are life-threatening complications of bon...
Chronic graft versus host disease (cGVHD) is the leading cause of non-relapse mortality after alloge...